Last update 14 Jun 2025

Firategrast

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Firategrast (USAN), SB-683699, T-0047
Action
antagonists
Mechanism
α4β1 antagonists(Integrin alpha-4/beta-1 antagonists), α4β7 antagonists(Integrin alpha-4/beta-7 antagonists)
Active Indication-
Originator Organization
Active Organization-
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC27H27F2NO6
InChIKeyYLFZHHDVRSYTKT-NRFANRHFSA-N
CAS Registry402567-16-2

External Link

KEGGWikiATCDrug Bank
D06590--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Crohn DiseasePhase 2
United States
01 Oct 2004
Crohn DiseasePhase 2
Canada
01 Oct 2004
Multiple sclerosis relapsePhase 2
Belgium
01 Sep 2004
Multiple sclerosis relapsePhase 2
Germany
01 Sep 2004
Multiple sclerosis relapsePhase 2
Poland
01 Sep 2004
Multiple sclerosis relapsePhase 2
Russia
01 Sep 2004
Multiple sclerosis relapsePhase 2
Spain
01 Sep 2004
Multiple Sclerosis, Relapsing-RemittingPhase 2
Belgium
01 Sep 2004
Multiple Sclerosis, Relapsing-RemittingPhase 2
Germany
01 Sep 2004
Multiple Sclerosis, Relapsing-RemittingPhase 2
Poland
01 Sep 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free